We are live on
!
Find out more
GP
Geneva Partners Portfolio holdings
AUM
$208M
1-Year Est. Return
72.91%
This Fund
S&P 500
This Quarter
Est. Return
+18.04%
1 Year Est. Return
+72.91%
3 Year Est. Return
+251.81%
5 Year Est. Return
+429.32%
10 Year Est. Return
–
AUM
$117M
AUM Growth
+$30.8M
(+36%)
Cap. Flow
+$17.6M
Cap. Flow
% of AUM
15.04%
Top 10 Holdings %
Top 10 Hldgs %
36.17%
Holding
72
New
15
Increased
18
Reduced
27
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity Dividend ETF for Rising Rates
FDRR
|
+$3.8M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$3.63M |
| 3 |
Edwards Lifesciences
EW
|
+$2.65M |
| 4 |
Alexandria Real Estate Equities
ARE
|
+$2.23M |
| 5 |
Woodward
WWD
|
+$2.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$3.26M |
| 2 |
UnitedHealth
UNH
|
+$2.71M |
| 3 |
Caterpillar
CAT
|
+$2.59M |
| 4 |
Citigroup
C
|
+$2.12M |
| 5 |
Emerson Electric
EMR
|
+$568K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.58% |
| 2 | Technology | 11.61% |
| 3 | Industrials | 11.27% |
| 4 | Consumer Discretionary | 10.66% |
| 5 | Financials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Fidelity Dividend ETF for Rising Rates
FDRR
$735M
| $5.56M | 4.74% |
176,128
+123,558
| +235% | +$3.8M |
|
2
Alphabet (Google) Class A
GOOGL
$4.1T
| $5.04M | 4.3% |
85,680
+5,620
| +7% | +$317K |
|
3
Starbucks
SBUX
$119B
| $4.19M | 3.57% |
56,320
+5,400
| +11% | +$371K |
|
4
Nike
NKE
$63.2B
| $4.15M | 3.54% |
49,332
-3,510
| -7% | -$290K |
|
|
XLNX
5
DELISTED
Xilinx Inc
XLNX
| $4.1M | 3.49% |
+32,313
| New | +$3.63M |
|
6
Dollar General
DG
$28.2B
| $3.99M | 3.4% |
33,455
-1,170
| -3% | -$136K |
|
7
Walt Disney
DIS
$171B
| $3.89M | 3.31% |
35,012
-2,963
| -8% | -$331K |
|
8
PayPal
PYPL
$50.5B
| $3.88M | 3.31% |
37,414
+10,935
| +41% | +$1.04M |
|
9
Amazon
AMZN
$2.46T
| $3.86M | 3.29% |
43,380
-700
| -2% | -$58.3K |
|
10
Microsoft
MSFT
$2.94T
| $3.75M | 3.2% |
31,820
+17,916
| +129% | +$1.95M |
|
11
JPMorgan Chase
JPM
$927B
| $3.6M | 3.07% |
35,556
-3,330
| -9% | -$343K |
|
12
Becton Dickinson
BDX
$46.4B
| $3.52M | 3% |
14,430
-1,343
| -9% | -$317K |
|
13
Zoetis
ZTS
$33B
| $3.36M | 2.87% |
33,390
+16,720
| +100% | +$1.52M |
|
14
iShares Core S&P 500 ETF
IVV
$863B
| $3.25M | 2.77% |
11,415
+130
| +1% | +$35.5K |
|
|
15
Edwards Lifesciences
EW
$49.1B
| $2.99M | 2.55% |
+46,350
| New | +$2.65M |
|
16
Thermo Fisher Scientific
TMO
$214B
| $2.73M | 2.32% |
10,310
+1,165
| +13% | +$290K |
|
17
Abbott
ABT
$191B
| $2.71M | 2.31% |
33,948
+2,910
| +9% | +$217K |
|
18
iShares MSCI USA Quality Factor ETF
QUAL
$45.9B
| $2.69M | 2.3% |
30,417
+11,757
| +63% | +$989K |
|
19
ServiceNow
NOW
$120B
| $2.51M | 2.14% |
50,975
+37,475
| +278% | +$1.65M |
|
|
20
Alexandria Real Estate Equities
ARE
$9.53B
| $2.41M | 2.06% |
+16,935
| New | +$2.23M |
|
|
21
Woodward
WWD
$23.3B
| $2.27M | 1.93% |
+23,890
| New | +$2.11M |
|
22
Bank of America
BAC
$433B
| $2.17M | 1.85% |
78,725
-2,800
| -3% | -$79.1K |
|
23
Trane Technologies
TT
$98.3B
| $1.99M | 1.7% |
18,425
-1,160
| -6% | -$118K |
|
24
Palo Alto Networks
PANW
$253B
| $1.98M | 1.69% |
48,882
+1,404
| +3% | +$52.1K |
|
25
Armstrong World Industries
AWI
$7.32B
| $1.88M | 1.6% |
+23,610
| New | +$1.65M |
|
Similar funds
SPFA
SWM
BWM
EPG
MCP
EM
MIM
MIP
Geneva Partners's Q1 2019 Portfolio in Review
As of Q1 2019, Geneva Partners held 72 positions worth $117M, up 36% from $86.5M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Geneva Partners deployed $17.6M of net new capital in Q1 2019, opening 15 new positions and adding to 18 existing holdings. Its largest new stake was Xilinx Inc: 32,313 shares worth $4.1M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 23% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $451K trimmed.
- Geneva Partners's largest Q1 2019 buy was Xilinx Inc: 32,313 shares worth $4.1M.
- Geneva Partners added most to Fidelity Dividend ETF for Rising Rates in Q1 2019, an estimated $3.8M increase.
- Geneva Partners's biggest Q1 2019 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $451K.
- Geneva Partners fully exited CVS Health in Q1 2019, selling an estimated $3.26M.
- Geneva Partners's ten largest holdings make up 36% of its $117M portfolio in Q1 2019.
- Geneva Partners opened 15 new positions and closed 10 in Q1 2019.
- Geneva Partners's portfolio value rose 36% quarter-over-quarter to $117M.
Based on Geneva Partners's 13F filing for Q1 2019, filed 10 May 2019.